Target risk factors for dementia prevention: A systematic review and Delphi consensus study on the evidence from observational studies

International Journal of Geriatric Psychiatry

Volumn 30, Issue 3, 2015, Pages 234-246

  Deckers, Kay ^a   Van Boxtel, Martin P J ^a   Schiepers, Olga J G ^a   De Vugt, Marjolein ^a   Sánchez, Juan Luis Muñoz ^b   Anstey, Kaarin J ^c   Brayne, Carol ^d   Dartigues, Jean Francois ^e   Engedal, Knut ^f   Kivipelto, Miia ^g   Ritchie, Karen ^e   Starr, John M ^h   Yaffe, Kristine ⁱ   Irving, Kate ^j   Verhey, Frans R J ^a   Köhler, Sebastian ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b Hospital Provincial de Zamora   (Spain)

^c AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^e INSERM   (France)

^f OSLO UNIVERSITY HOSPITAL   (Norway)

^g KAROLINSKA INSTITUTE   (Sweden)

^h UNIVERSITY OF EDINBURGH   (United Kingdom)

ⁱ UNIVERSITY OF CALIFORNIA   (United States)

^j DUBLIN CITY UNIVERSITY   (Ireland)

more..

Author keywords

Dementia; Epidemiology; Prevention; Public health; Risk factors

Indexed keywords

CHOLESTEROL; UNSATURATED FATTY ACID;

COGNITION; CONSENSUS; DELPHI STUDY; DEMENTIA; DEPRESSION; DIABETES MELLITUS; DIET SUPPLEMENTATION; EPIDEMIOLOGICAL DATA; FAT INTAKE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INFLAMMATION; ISCHEMIC HEART DISEASE; KIDNEY DYSFUNCTION; MEDLINE; META ANALYSIS (TOPIC); NATIONAL HEALTH ORGANIZATION; OBESITY; OBSERVATIONAL STUDY; PATIENT RISK; PHYSICAL ACTIVITY; PHYSICAL INACTIVITY; QUALITY CONTROL; REVIEW; RISK ASSESSMENT; RISK FACTOR; SMOKING; SYSTEMATIC REVIEW; TRIANGULATION; COMORBIDITY; LIFESTYLE; MOTOR ACTIVITY;

COGNITION; COMORBIDITY; DELPHI TECHNIQUE; DEMENTIA; HUMANS; LIFE STYLE; MOTOR ACTIVITY; OBSERVATIONAL STUDY AS TOPIC; RISK FACTORS;

EID: 84921849274     PISSN: 08856230     EISSN: 10991166     Source Type: Journal    
DOI: 10.1002/gps.4245     Document Type: Review

References (189)

1. Abbatecola AM, Lattanzio F, Spazzafumo L, et al. 2010. Adiposity predicts cognitive decline in older persons with diabetes: a 2-year follow-up. PLoS One 5: e10333.
2. Agarwal DP. 2002. Cardioprotective effects of light-moderate consumption of alcohol: a review of putative mechanisms. Alcohol Alcohol 37: 409-415.
3. Alonso A, Mosley TH Jr., Gottesman RF, et al . 2009. Risk of dementia hospitalisation associated with cardiovascular risk factors in midlife and older age: the Atherosclerosis Risk in Communities (ARIC) study. J Neurol Neurosurg Psychiatry 80:1194-1201.
4. Alzheimer's Association and Centers for Disease Control and Prevention. 2013. The Healthy Brain Initiative: The Public Health Road Map for State and National Partnerships, 2013-2018. Alzheimer's Association: Chicago, IL.
5. Angevaren M, Vanhees L, Nooyens AC, Wendel-Vos CG, Verschuren WM. 2010. Physical activity and 5-year cognitive decline in the Doetinchem cohort study. Ann Epidemiol 20: 473-479.
6. Anstey KJ, Cherbuin N, Herath PM. 2013. Development of a new method for assessing global risk of Alzheimer's disease for use in population health approaches to prevention. Prev Sci 14: 411-421.
7. Anstey KJ, Lipnicki DM, Low LF. 2008. Cholesterol as a risk factor for dementia and cognitive decline: a systematic review of prospective studies with meta-analysis. Am J Geriatr Psychiatry 16: 343-354.
8. Anstey KJ, Mack HA, Cherbuin N. 2009. Alcohol consumption as a risk factor for dementia and cognitive decline: meta-analysis of prospective studies. Am J Geriatr Psychiatry 17 : 542-555.
9. Barnes DE, Yaffe K. 2011. The projected effect of risk factor reduction on Alzheimer's disease prevalence. Lancet Neurol 10: 819-828.
10. Barzilay JI, Gao P, O'Donnell M, et al. 2011. Albuminuria and decline in cognitive function: the ONTARGET/TRANSCEND studies. Arch Intern Med 171: 142-150.
11. Benetos A, Watfa G, Hanon O, et al. 2012. Pulse wave velocity is associated with 1- year cognitive decline in the elderly older than 80 years: the PARTAGE study. J Am Med Dir Assoc 13: 239-243.
12. Bennett DA, Wilson RS, Arvanitakis Z, et al. 2013. Selected findings from the Religious Orders Study and Rush Memory and Aging Project. J Alzheimers Dis 33 (Suppl 1): S397-S403.
13. Bermejo-Pareja F, Benito-Leon J, Louis ED, et al. 2010. Risk of incident dementia in drug-untreated arterial hypertension: a population-based study. J Alzheimers Dis 22 : 949-958.
14. Beydoun MA, Beason-Held LL, Kitner-Triolo MH, et al. 2011. Statins and serum cholesterol's associations with incident dementia and mild cognitive impairment. J Epidemiol Community Health 65: 949-957.
15. Bielak AA, Gerstorf D, Kiely KM, Anstey KJ, Luszcz M. 2011. Depressive symptoms predict decline in perceptual speed in older adulthood. Psychol Aging 26: 576-583.
16. Boyle LL, Porsteinsson AP, Cui X, King DA, Lyness JM. 2010. Depression predicts cognitive disorders in older primary care patients. J Clin Psychiatry 71: 74-79.
17. Buchman AS, Boyle PA, Yu L, et al. 2012. Total daily physical activity and the risk of AD and cognitive decline in older adults. Neurology 78: 1323-1329.
18. Bugnicourt JM, Godefroy O, Chillon JM, Choukroun G, Massy ZA. 2013. Cognitive disorders and dementia in CKD: the neglected kidney-brain axis. J Am Soc Nephrol 24: 353-363.
19. Bunch TJ, Crandall BG, Weiss JP, et al. 2011. Patients treated with catheter ablation for atrial fibrillation have long-term rates of death, stroke, and dementia similar to patients without atrial fibrillation. J Cardiovasc Electrophysiol 22: 839-845.
20. Bunch TJ, Weiss JP, Crandall BG, et al. 2010. Atrial fibrillation is independently associated with senile, vascular, and Alzheimer's dementia. Heart Rhythm 7: 433-437.
21. Burns M, Duff K. 2002. Cholesterol in Alzheimer's disease and tauopathy. Ann N Y Acad Sci 977: 367-375.
22. Butters MA, Young JB, Lopez O, et al. 2008. Pathways linking late-life depression to persistent cognitive impairment and dementia. Dialogues Clin Neurosci 10: 345-357.
23. Caselli RJ, Dueck AC, Locke DE, et al. 2011. Cerebrovascular risk factors and preclinical memory decline in healthy APOE epsilon4 homozygotes. Neurology 76: 1078-1084.
24. Chen R, Hu Z, Wei L, et al. 2011. Incident dementia in a defined older Chinese population. PLoS One 6: e24817.
25. Cheng D, Noble J, Tang MX, et al. 2011. Type 2 diabetes and late-onset Alzheimer's disease. Dement Geriatr Cogn Disord 31: 424-430.
26. Cherbuin N, Anstey KJ. 2012. The Mediterranean diet is not related to cognitive change in a large prospective investigation: the PATH Through Life study. Am J Geriatr Psychiatry 20: 635-639.
27. Chodosh J, Miller-Martinez D, Aneshensel CS, Wight RG, Karlamangla AS. 2010. Depressive symptoms, chronic diseases, and physical disabilities as predictors of cognitive functioning trajectories in older Americans. J Am Geriatr Soc 58: 2350-2357.
28. Christman AL, Matsushita K, Gottesman RF, et al . 2011. Glycated haemoglobin and cognitive decline: the Atherosclerosis Risk in Communities (ARIC) study. Diabetologia 54: 1645-1652.
29. Collins N, Sachs-Ericsson N, Preacher KJ, Sheffield KM, Markides K. 2009. Smoking increases risk for cognitive decline among community-dwelling older Mexican Americans. Am J Geriatr Psychiatry 17: 934-942.
30. Commenges D, Scotet V, Renaud S, et al. 2000. Intake of flavonoids and risk of dementia. Eur J Epidemiol 16: 357-363.
31. Creavin ST, Gallacher J, Bayer A, et al. 2012. Metabolic syndrome, diabetes, poor cognition, and dementia in the Caerphilly prospective study. J Alzheimers Dis 28: 931-939.
32. Crowe M, Sartori A, Clay OJ, et al. 2010. Diabetes and cognitive decline: investigating the potential influence of factors related to health disparities. J Aging Health 22: 292-306.
33. Dahl A, Hassing LB, Fransson E, et al. 2010. Being overweight in midlife is associated with lower cognitive ability and steeper cognitive decline in late life. J Gerontol A Biol Sci Med Sci 65: 57-62.
34. Dalkey N, Helmer O. 1963. An experimental application of the DELPHI method to the use of experts. Manage Sci 9: 458-467.
35. Debette S, Seshadri S, Beiser A, et al. 2011. Midlife vascular risk factor exposure accelerates structural brain aging and cognitive decline. Neurology 77: 461-468.
36. Devore EE, Grodstein F, van Rooij FJ, et al . 2009. Dietary intake of fish and omega-3 fatty acids in relation to long-term dementia risk. Am J Clin Nutr 90: 170-176.
37. Diniz BS, Butters MA, Albert SM, Dew MA, Reynolds CF 3rd 2013. Late-life depression and risk of vascular dementia and Alzheimer's disease: systematic review and meta-analysis of community-based cohort studies. Br J Psychiatry 202: 329-335.
38. Dlugaj M, Gerwig M, Wege N, et al. 2012. Elevated levels of high-sensitivity C-reactive protein are associated with mild cognitive impairment and its subtypes: results of a population-based case-control study. J Alzheimers Dis 28: 503-514.
39. Dolcos S, MacDonald SW, Braslavsky A, Camicioli R, Dixon RA. 2012. Mild cognitive impairment is associated with selected functional markers: integrating concurrent, longitudinal, and stability effects. Neuropsychology 26: 209-223.
40. Dotson VM, Beydoun MA, Zonderman AB. 2010. Recurrent depressive symptoms and the incidence of dementia and mild cognitive impairment. Neurology 75: 27-34.
41. Dublin S, Anderson ML, Haneuse SJ, et al. 2011. Atrial fibrillation and risk of dementia: a prospective cohort study. J Am Geriatr Soc 59: 1369-1375.
42. Eriksson UK, Bennet AM, Gatz M, Dickman PW, Pedersen NL. 2010. Nonstroke cardiovascular disease and risk of Alzheimer disease and dementia. Alzheimer Dis Assoc Disord 24: 213-219.
43. Eriksson Sorman D, Sundstrom A, Ronnlund M, Adolfsson R, Nilsson LG. 2014. Leisure activity in old age and risk of dementia: a 15-year prospective study. J Gerontol B Psychol Sci Soc Sci 69: 493-501.
44. Etgen T, Chonchol M, Forstl H, Sander D. 2012. Chronic kidney disease and cognitive impairment: a systematic review and meta-analysis. Am J Nephrol 35: 474-482.
45. Euser SM, Sattar N, Witteman JC, et al. 2010. A prospective analysis of elevated fasting glucose levels and cognitive function in older people: results from PROSPER and the Rotterdam Study. Diabetes 59: 1601-1607.
46. Farrow M. 2008. Dementia risk reduction: what do Australians know. Available from: http://www.yourbrainmatters.org.au/sites/default/files/Dementia%20Risk%20Re-duction- What%20do%20Australians%20know.pdf (Accessed on 30 July 2013).
47. Feng L, Yap KB, Yeoh LY, Ng TP. 2012. Kidney function and cognitive and functional decline in elderly adults: findings from the Singapore longitudinal aging study. J Am Geriatr Soc 60: 1208-1214.
48. Ferri CP, Prince M, Brayne C, et al. 2005. Global prevalence of dementia: a Delphi consensus study. Lancet 366: 2112-2117.
49. Folstein MF, Folstein SE, McHugh PR. 1975. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12: 189-198.
50. Forti P, Pisacane N, Rietti E, et al. 2010. Metabolic syndrome and risk of dementia in older adults. J Am Geriatr Soc 58: 487-492.
51. Gallacher J, Bayer A, Lowe G, et al. 2010. Is sticky blood bad for the brain?: Hemostatic and inflammatory systems and dementia in the Caerphilly Prospective Study. Arterioscler Thromb Vasc Biol 30: 599-604.
52. Gao Q, Niti M, Feng L, Yap KB, Ng TP. 2011. Omega-3 polyunsaturated fatty acid supplements and cognitive decline: Singapore Longitudinal Aging Studies. J Nutr Health Aging 15: 32-35.
53. Gaussoin SA, Espeland MA, Absher J, et al. 2012. Ascertaining dementia-related outcomes for deceased or proxy-dependent participants: an overview of the Women's Health Initiative Memory Study supplemental case ascertainment protocol. Int J Geriatr Psychiatry 27: 205-214.
54. Gelber RP, Petrovitch H, Masaki KH, et al. 2012. Lifestyle and the risk of dementia in Japanese-American men. J Am Geriatr Soc 60: 118-123.
55. Gillette-Guyonnet S, Andrieu S, Dantoine T, et al. 2009. Commentary on "A roadmap for the prevention of dementia II. Leon Thal Symposium 2008." The Multidomain Alzheimer Preventive Trial (MAPT): a new approach to the prevention of Alzheimer's disease. Alzheimers Dement 5 : 114-121.
56. Goveas JS, Espeland MA, Woods NF, Wassertheil-Smoller S, Kotchen JM. 2011. Depressive symptoms and incidence of mild cognitive impairment and probable dementia in elderly women: the Women's Health Initiative Memory Study. J Am Geriatr Soc 59: 57-66.
57. Graham JE, Rockwood K, Beattie BL, et al. 1997. Prevalence and severity of cognitive impairment with and without dementia in an elderly population. Lancet 349: 1793-1796.
58. Greendale GA, Wight RG, Huang MH, et al. 2010. Menopause-associated symptoms and cognitive performance: results from the study of women's health across the nation. Am J Epidemiol 171: 1214-1224.
59. Gu Y, Luchsinger JA, Stern Y, Scarmeas N. 2010a. Mediterranean diet, inflammatory and metabolic biomarkers, and risk of Alzheimer's disease. J Alzheimers Dis 22: 483-492.
60. Gu Y, Nieves JW, Stern Y, Luchsinger JA, Scarmeas N. 2010b. Food combination and Alzheimer disease risk: a protective diet. Arch Neurol 67: 699-706.
61. Guan JW, Huang, CQ, Li YH, et al. 2011. No association between hypertension and risk for Alzheimer's disease: a meta-analysis of longitudinal studies. J Alzheimers Dis 27: 799-807.
62. Gustafson D. 2006. Adiposity indices and dementia. Lancet Neurol 5: 713-720.
63. Gustafson DR, Backman K, Waern M, et al. 2009. Adiposity indicators and dementia over 32 years in Sweden. Neurology 73: 1559-1566.
64. Hajjar I, Quach L, Yang F, et al. 2011. Hypertension, white matter hyperintensities, and concurrent impairments in mobility, cognition, and mood: the Cardiovascular Health Study. Circulation 123: 858-865.
65. Hamer M, Chida Y. 2009. Physical activity and risk of neurodegenerative disease: a systematic review of prospective evidence. Psychol Med 39: 3-11.
66. Hassing LB, Dahl AK, Pedersen NL, Johansson B. 2010. Overweight in midlife is related to lower cognitive function 30 years later: a prospective study with longitudinal assessments. Dement Geriatr Cogn Disord 29: 543-552.
67. Hebert LE, Weuve J, Scherr PA, Evans DA. 2013. Alzheimer disease in the United States (2010-2050) estimated using the 2010 census. Neurology 80: 1778-1783.
68. Helmer C, Stengel B, Metzger M, et al. 2011. Chronic kidney disease, cognitive decline, and incident dementia: the 3C Study. Neurology 77: 2043-2051.
69. HHS. 2004. The 2004 United States Surgeon General's Report: The Health Consequences of Smoking. United States Department of Health and Human Services.
70. Hjelm C, Dahl A, Brostrom A, et al. 2012. The influence of heart failure on longitudinal changes in cognition among individuals 80 years of age and older. J Clin Nurs 21 : 994-1003.
71. Hughes TF, Ganguli M. 2009. Modifiable midlife risk factors for late-life cognitive impairment and dementia. Curr Psychiatry Rev 5: 73-92.
72. Hurd MD, Martorell P, Delavande A, Mullen KJ, Langa KM. 2013. Monetary costs of dementia in the United States. N Engl J Med 368: 1326-1334.
73. Ikram MA, Vernooij MW, Hofman A, et al. 2008. Kidney function is related to cerebral small vessel disease. Stroke 39: 55-61.
74. Jajodia A, Borders A. 2011. Memory predicts changes in depressive symptoms in older adults: a bidirectional longitudinal analysis. J Gerontol B Psychol Sci Soc Sci 66 : 571-581.
75. Jassal SK, Kritz-Silverstein D, Barrett-Connor E. 2010. A prospective study of albuminuria and cognitive function in older adults: the Rancho Bernardo study. Am J Epidemiol 171: 277-286.
76. Jedrziewski MK, Ewbank DC, Wang H, Trojanowski JQ. 2010. Exercise and cognition: results from the National Long Term Care Survey. Alzheimers Dement 6: 448-455.
77. Jenny NS, French B, Arnold AM, et al. 2012. Long-term assessment of inflammation and healthy aging in late life: the Cardiovascular Health Study All Stars. J Gerontol A Biol Sci Med Sci 67: 970-976.
78. Joas E, Backman K, Gustafson D, et al. 2012. Blood pressure trajectories from midlife to late life in relation to dementia in women followed for 37 years. Hypertension 59: 796-801.
79. Johansson L, Guo X, Waern M, et al. 2010. Midlife psychological stress and risk of dementia: a 35-year longitudinal population study. Brain 133 : 2217-2224.
80. Johnson W, Price JF, Rafnsson SB, Deary IJ, Fowkes FG. 2010. Ankle--brachial index predicts level of, but not change in, cognitive function: the Edinburgh Artery Study at the 15-year follow-up. Vasc Med 15: 91-97.
81. Justin BN, Turek M, Hakim AM. 2013. Heart disease as a risk factor for dementia. Clin Epidemiol 5: 135-145.
82. Kalantarian S, Stern TA, Mansour M, Ruskin JN. 2013. Cognitive impairment associated with atrial fibrillation: a meta-analysis. Ann Intern Med 158: 338-346.
83. Kerola T, Nieminen T, Sulkava R, et al. 2012. Inverted mitral in flow pattern in echocardiography among the elderly - a marker of non-cardiovascular mortality and cognitive dysfunction. Int J Cardiol 155: 70-74.
84. Kerwin DR, Gaussoin SA, Chlebowski RT, et al. 2011. Interaction between body mass index and central adiposity and risk of incident cognitive impairment and dementia: results from the Women's Health Initiative Memory Study. J Am Geriatr Soc 59 : 107-112.
85. Khatri M, Nickolas T, Moon YP, et al. 2009. CKD associates with cognitive decline. J Am Soc Nephrol 20: 2427-2432.
86. Kim JM, Stewart R, Bae KY, et al. 2011a. Role of BDNF val66met polymorphism on the association between physical activity and incident dementia. Neurobiol Aging 32 (551): e5-e12.
87. Kim JM, Stewart R, Kim SY, et al. 2011b. Synergistic associations of depression and apolipoprotein E genotype with incidence of dementia. Int J Geriatr Psychiatry 26 : 893-898.
88. Kimm H, Lee PH, Shin YJ, et al. 2011. Mid-life and late-life vascular risk factors and dementia in Korean men and women. Arch Gerontol Geriatr 52: e117-e122.
89. Kivipelto M, Solomon A, Ahtiluoto S, et al. 2013. The Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER): study design and progress. Alzheimers Dement 9: 657-665.
90. Köhler S, van Boxtel M, Jolles J, Verhey F. 2011. Depressive symptoms and risk for dementia: a 9-year follow-up of the Maastricht Aging Study. Am J Geriatr Psychiatry 19: 902-905.
91. Koyama A, O'Brien J, Weuve J, et al. 2013. The role of peripheral inflammatory markers in dementia and Alzheimer' s disease: a meta-analysis. J Gerontol A Biol Sci Med Sci 68: 433-440.
92. Ku PW, Stevinson C, Chen LJ. 2012. Prospective associations between leisure-time physical activity and cognitive performance among older adults across an 11-year period. J Epidemiol 22: 230-237.
93. Kurella Tamura M, Muntner P, Wadley V, et al. 2011. Albuminuria, kidney function, and the incidence of cognitive impairment among adults in the United States. Am J Kidney Dis 58: 756-763.
94. Kwok CS, Loke YK, Hale R, Potter JF, Myint PK. 2011. Atrial fibrillation and incidence of dementia: a systematic review and meta-analysis. Neurology 76 : 914-922.
95. Launer LJ, Hughes T, Yu B, et al. 2010. Lowering midlife levels of systolic blood pressure as a public health strategy to reduce late-life dementia: perspective from the Honolulu Heart Program/Honolulu Asia Aging Study. Hypertension 55: 1352-1359.
96. Laurin D, David Curb J, Masaki KH, White LR, Launer LJ. 2009. Midlife C-reactive protein and risk of cognitive decline: a 31-year follow-up. Neurobiol Aging 30: 1724-1727.
97. Lenoir H, Dufouil C, Auriacombe S, et al. 2011. Depression history, depressive symptoms, and incident dementia: the 3C Study. J Alzheimers Dis 26: 27-38.
98. Li G, Wang LY, Shofer JB, et al. 2011. Temporal relationship between depression and dementia: findings from a large community-based 15-year follow-up study. Arch Gen Psychiatry 68: 970-977.
99. Lobo E, Dufouil C, Marcos G, et al . 2010. Is there an association between low-tomoderate alcohol consumption and risk of cognitive decline? Am J Epidemiol 172: 708-716.
100. Lopez LB, Kritz-Silverstein D, Barrett Connor E. 2011. High dietary and plasma levels of the omega-3 fatty acid docosahexaenoic acid are associated with decreased dementia risk: the Rancho Bernardo study. J Nutr Health Aging 15: 25-31.
101. Lourida I, Soni M, Thompson-Coon J, et al. 2013. Mediterranean diet, cognitive function, and dementia: a systematic review. Epidemiology 24: 479-489.
102. Lu FP, Lin KP, Kuo HK. 2009. Diabetes and the risk of multi-system aging phenotypes: a systematic review and meta-analysis. PLoS One 4: e4144.
103. Luchsinger JA, Cheng D, Tang MX, Schupf N, Mayeux R. 2012. Central obesity in the elderly is related to late-onset Alzheimer disease. Alzheimer Dis Assoc Disord 26: 101-105.
104. Marengoni A, Qiu C, Winblad B, Fratiglioni L. 2011. Atrial fibrillation, stroke and dementia in the very old: a population-based study. Neurobiol Aging 32: 1336-1337.
105. Marquie JC, Duarte LR, Bessieres P, et al. 2010. Higher mental stimulation at work is associated with improved cognitive functioning in both young and older workers. Ergonomics 53: 1287-1301.
106. Matthews FE, Arthur A, Barnes LE, et al. 2013. A two-decade comparison of prevalence of dementia in individuals aged 65 years and older from three geographical areas of England: results of the Cognitive Function and Ageing Study I and II. Lancet 382: 1405-1412.
107. Mazereeuw G, Lanctot KL, Chau SA, Swardfager W, Herrmann N. 2012. Effects of omega-3 fatty acids on cognitive performance: a meta-analysis. Neurobiol Aging 33(1482): e17-e29.
108. McGeer EG, McGeer PL. 2010. Neuroinflammation in Alzheimer's disease and mild cognitive impairment: a field in its infancy. J Alzheimers Dis 19: 355-361.
109. Mejia-Arango S, Gutierrez LM. 2011. Prevalence and incidence rates of dementia and cognitive impairment no dementia in the Mexican population: data from the Mexican Health and Aging Study. J Aging Health 23: 1050-1074.
110. Mielke MM, Zandi PP, Shao H, et al. 2010. The 32-year relationship between cholesterol and dementia from midlife to late life. Neurology 75: 1888-1895.
111. Mooijaart SP, Sattar N, Trompet S, et al. 2011. C-reactive protein and genetic variants and cognitive decline in old age: the PROSPER study. PLoS One 6: e23890.
112. Morris MC, Evans DA, Bienias JL, et al. 2003. Consumption of fish and n-3 fatty acids and risk of incident Alzheimer disease. Arch Neurol 60: 940-946.
113. MRC-CFAS. 2001. Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Neuropathology Group of the Medical Research Council Cognitive Function and Ageing Study (MRCCFAS). Lancet 357: 169-175.
114. Murray AD, Staff RT, McNeil CJ, et al. 2012. Brain lesions, hypertension and cognitive ageing in the 1921 and 1936 Aberdeen birth cohorts. Age (Dordr) 34 : 451-459.
115. Naqvi AZ, Harty B, Mukamal KJ, et al. 2011. Monounsaturated, trans, and saturated Fatty acids and cognitive decline in women. J Am Geriatr Soc 59: 837-843.
116. Ninomiya T, Ohara T, Hirakawa Y, et al. 2011. Midlife and late-life blood pressure and dementia in Japanese elderly: the Hisayama study. Hypertension 58: 22-28.
117. Ogunniyi A, Lane KA, Baiyewu O, et al . 2011. Hypertension and incident dementia in community-dwelling elderly Yoruba Nigerians. Acta Neurol Scand 124: 396-402.
118. Ohara T, Doi Y, Ninomiya T, et al. 2011. Glucose tolerance status and risk of dementia in the community: the Hisayama study. Neurology 77: 1126-1134.
119. Ownby RL, Crocco E, Acevedo A, John V, Loewenstein D. 2006. Depression and risk for Alzheimer disease: systematic review, meta-analysis, and metaregression analysis. Arch Gen Psychiatry 63: 530-538.
120. Park SA. 2011. A common pathogenic mechanism linking type-2 diabetes and Alzheimer's disease: evidence from animal models. J Clin Neurol 7: 10-18.
121. Peters R, Pinto E, Beckett N, et al . 2010. Association of depression with subsequent mortality, cardiovascular morbidity and incident dementia in people aged 80 and over and suffering from hypertension. Data from the Hypertension in the Very Elderly Trial (HYVET). Age Ageing 39: 439-445.
122. Peters R, Poulter R, Warner J, et al. 2008. Smoking, dementia and cognitive decline in the elderly, a systematic review. BMC Geriatr 8: 36.
123. Petersen RC, Smith GE, Waring SC, et al. 1999. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 56 : 303-308.
124. Plassman BL, Williams JW Jr., Burke JR, Holsinger T, Benjamin S. 2010. Systematic review: factors associated with risk for and possible prevention of cognitive decline in later life. Ann Intern Med 153: 182-193.
125. Potvin O, Forget H, Grenier S, Preville M, Hudon C. 2011. Anxiety, depression, and 1-year incident cognitive impairment in community-dwelling older adults. J Am Geriatr Soc 59: 1421-1428.
126. Power BD, Alfonso H, Flicker L, et al. 2011a. Body adiposity in later life and the incidence of dementia: the health in men study. PLoS One 6: e17902.
127. Power MC, Weuve J, Gagne JJ, et al. 2011b. The association between blood pressure and incident Alzheimer disease: a systematic review and meta-analysis. Epidemiology 22: 646-659.
128. Provenzano FA, Muraskin J, Tosto G, et al. 2013. White matter hyperintensities and cerebral amyloidosis: necessary and sufficient for clinical expression of Alzheimer disease? JAMA Neurol 70: 455-461.
129. Psaltopoulou T, Sergentanis TN, Panagiotakos DB, et al. 2013. Mediterranean diet, stroke, cognitive impairment, and depression: a meta-analysis. Ann Neurol 74: 580-591.
130. Qiu C. 2012. Preventing Alzheimer's disease by targeting vascular risk factors: hope and gap. J Alzheimers Dis 32: 721-731.
131. Qiu WQ, Folstein MF. 2006. Insulin, insulin-degrading enzyme and amyloid-beta peptide in Alzheimer's disease: review and hypothesis. Neurobiol Aging 27: 190-198.
132. Rastas S, Pirttila T, Mattila K, et al. 2010. Vascular risk factors and dementia in the general population aged >85 years: prospective population-based study. Neurobiol Aging 31: 1-7.
133. Reid PC, Urano Y, Kodama T, Hamakubo T. 2007. Alzheimer' s disease: cholesterol, membrane rafts, isoprenoids and statins. J Cell Mol Med 11: 383-392.
134. Reitz C, Tang MX, Luchsinger J, Mayeux R. 2004. Relation of plasma lipids to Alzheimer disease and vascular dementia. Arch Neurol 61: 705-714.
135. Reitz C, Tang MX, Schupf N, et al. 2010a. Association of higher levels of high-density lipoprotein cholesterol in elderly individuals and lower risk of late-onset Alzheimer disease. Arch Neurol 67: 1491-1497.
136. Reitz C, Tang MX, Schupf N, et al. 2010b. A summary risk score for the prediction of Alzheimer disease in elderly persons. Arch Neurol 67: 835-841.
137. Reynolds CA, Gatz M, Prince JA, Berg S, Pedersen NL. 2010. Serum lipid levels and cognitive change in late life. J Am Geriatr Soc 58: 501-509.
138. Richard E, Andrieu S, Solomon A, et al. 2012. Methodological challenges in designing dementia prevention trials - the European Dementia Prevention Initiative (EDPI). J Neurol Sci 322: 64-70.
139. Richard E, Van den Heuvel E, Moll van Charante EP, et al. 2009. Prevention of dementia by intensive vascular care (PreDIVA): a cluster-randomized trial in progress. Alzheimer Dis Assoc Disord 23: 198-204.
140. Ritchie K, Carriere I, Ritchie CW, et al. 2010. Designing prevention programmes to reduce incidence of dementia: prospective cohort study of modifiable risk factors. BMJ 341: c3885.
141. Ronnemaa E, Zethelius B, Lannfelt L, Kilander L. 2011. Vascular risk factors and dementia: 40-year follow-up of a population-based cohort. Dement Geriatr Cogn Disord 31: 460-466.
142. Rosenberg PB, Mielke MM, Xue QL, Carlson MC. 2010. Depressive symptoms predict incident cognitive impairment in cognitive healthy older women. Am J Geriatr Psychiatry 18: 204-211.
143. Royall DR, Palmer R, Chiodo LK, Polk, MJ. 2012. Depressive symptoms predict longitudinal change in executive control but not memory. Int J Geriatr Psychiatry 27: 89-96.
144. Rusanen M, Kivipelto M, Quesenberry CP Jr., Zhou J, Whitmer RA. 2011. Heavy smoking in midlife and long-term risk of Alzheimer disease and vascular dementia. Arch Intern Med 171: 333-339.
145. Rusanen M, Rovio S, Ngandu T, et al. 2010. Midlife smoking, apolipoprotein E and risk of dementia and Alzheimer's disease: a population-based cardiovascular risk factors, aging and dementia study. Dement Geriatr Cogn Disord 30 : 277-284.
146. Sabia S, Elbaz A, Dugravot A, et al. 2012. Impact of smoking on cognitive decline in early old age: the Whitehall II cohort study. Arch Gen Psychiatry 69: 627-635.
147. Saczynski JS, Beiser A, Seshadri S, et al. 2010. Depressive symptoms and risk of dementia: the Framingham Heart Study. Neurology 75: 35-41.
148. Sajjad I, Grodstein F, Kang JH, Curhan GC, Lin J. 2012. Kidney dysfunction and cognitive decline in women. Clin J Am Soc Nephrol 7: 437-443.
149. Samieri C, Feart C, Proust-Lima C, et al. 2011. Omega-3 fatty acids and cognitive decline: modulation by ApoEepsilon4 allele and depression. Neurobiol Aging 32: 2317 e13-22.
150. Sander K, Bickel H, Forstl H, et al. 2010. Carotid- intima media thickness is independently associated with cognitive decline. The INVADE study. Int J Geriatr Psychiatry 25: 389-394.
151. Santangeli P, Di Biase L, Bai R, et al. 2012. Atrial fibrillation and the risk of incident dementia: a meta-analysis. Heart Rhythm 9: 1761-1768.
152. Sasaki Y, Marioni R, Kasai M, et al. 2011. Chronic kidney disease: a risk factor for dementia onset: a population-based study. The Osaki-Tajiri Project. J Am Geriatr Soc 59 : 1175-1181.
153. Sattler C, Erickson KI, Toro P, Schroder J. 2011. Physical fitness as a protective factor for cognitive impairment in a prospective population-based study in Germany. J Alzheimers Dis 26: 709-718.
154. Sattler C, Toro P, Schonknecht P, Schroder J. 2012. Cognitive activity, education and socioeconomic status as preventive factors for mild cognitive impairment and Alzheimer's disease. Psychiatry Res 196: 90-95.
155. Scalco MZ, van Reekum R. 2006. Prevention of Alzheimer disease. Encouraging evidence. Can Fam Physician 52: 200-207.
156. Schrijvers EM, Verhaaren BF, Koudstaal PJ, et al. 2012. Is dementia incidence declining?: Trends in dementia incidence since 1990 in the Rotterdam Study. Neurology 78 : 1456-1463.
157. Shatenstein B, Ferland G, Belleville S, et al. 2012. Diet quality and cognition among older adults from the NuAge study. Exp Gerontol 47: 353-360.
158. Song F, Poljak A, Crawford J, et al. 2012. Plasma apolipoprotein levels are associated with cognitive status and decline in a community cohort of older individuals. PLoS One 7: e34078.
159. Staessen JA, Thijs L, Richart T, Odili AN, Birkenhager WH. 2011. Placebo-controlled trials of blood pressure-lowering therapies for primary prevention of dementia. Hypertension 57: e6-e7.
160. Sydenham E, Dangour AD, Lim WS. 2012. Omega 3 fatty acid for the prevention of cognitive decline and dementia. Cochrane Database Syst Rev 6: CD005379. DOI:10.1002/14651858.CD005379.pub3.
161. Tan ZS, Seshadri S, Beiser A, et al . 2003. Plasma total cholesterol level as a risk factor for Alzheimer disease: the Framingham Study. Arch Intern Med 163: 1053-1057.
162. The Lancet Neurology. 2013. The road map to integrated dementia prevention and care. Lancet Neurol 12: 839.
163. Thorvaldsson V, Skoog I, Hofer SM, et al. 2012. Nonlinear blood pressure effects on cognition in old age: separating between-person and within-person associations. Psychol Aging 27: 375-383.
164. Unverzagt FW, Guey LT, Jones RN, et al . 2012. Active cognitive training and rates of incident dementia. J Int Neuropsychol Soc 18: 669-677.
165. Unverzagt FW, McClure LA, Wadley VG, et al. 2011a. Vascular risk factors and cognitive impairment in a stroke-free cohort. Neurology 77: 1729-1736.
166. Unverzagt FW, Ogunniyi A, Taler V, et al. 2011b. Incidence and risk factors for cognitive impairment no dementia and mild cognitive impairment in African Americans. Alzheimer Dis Assoc Disord 25: 4-10.
167. Valenzuela M, Brayne C, Sachdev P, Wilcock G, Matthews F. 2011. Cognitive lifestyle and long-term risk of dementia and survival after diagnosis in a multicenter population-based cohort. Am J Epidemiol 173: 1004-1012.
168. van den Kommer TN, Dik MG, Comijs HC, Jonker C, Deeg DJ. 2012. Role of lipoproteins and inflammation in cognitive decline: do they interact? Neurobiol Aging 33(196): e1-e12.
169. van Oijen M, de Jong FJ, Witteman JC, et al. 2007. Atherosclerosis and risk for dementia. Ann Neurol 61: 403-410.
170. van Vliet P, Westendorp RG, van Heemst D, de Craen AJ, Oleksik AM. 2010. Cognitive decline precedes late-life longitudinal changes in vascular risk factors. J Neurol Neurosurg Psychiatry 81: 1028-1032.
171. Voss MW, Vivar C, Kramer AF, van Praag H. 2013. Bridging animal and human models of exercise-induced brain plasticity. Trends Cogn Sci 17: 525-544.
172. Wang CC, Lu TH, Liao WC, et al. 2010a. Cigarette smoking and cognitive impairment: a 10-year cohort study in Taiwan. Arch Gerontol Geriatr 51: 143-148.
173. Wang KC, Woung LC, Tsai MT, et al. 2012. Risk of Alzheimer's disease in relation to diabetes: a population-based cohort study. Neuroepidemiology 38: 237-244.
174. Wang F, Zhang L, Liu L, Wang H. 2010b. Level of kidney function correlates with cognitive decline. Am J Nephrol 32: 117-121.
175. Wells G, Shea B, O'connell D, et al. 2000. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Availabe from: http://www.ohri.ca/programs/clinical-epidemiology/oxford.htm (Accessed on 17 June 2013).
176. Wessels AM, Lane KA, Gao S, et al . 2011. Diabetes and cognitive decline in elderly African Americans: a 15-year follow-up study. Alzheimers Dement 7: 418-424.
177. Weuve J, Tchetgen Tchetgen EJ, Glymour MM, et al. 2012. Accounting for bias due to selective attrition: the example of smoking and cognitive decline. Epidemiology 23: 119-128.
178. Weyerer S, Schaufele M, Wiese B, et al. 2011. Current alcohol consumption and its relationship to incident dementia: results from a 3-year follow-up study among primary care attenders aged 75 years and older. Age Ageing 40: 456-463.
179. Whitmer RA. 2007. The epidemiology of adiposity and dementia. Curr Alzheimer Res 4: 117-122.
180. Williams JW, Plassman BL, Burke J, Holsinger T, Benjamin S. 2010. Preventing Alzheimer's Disease and Cognitive Decline. Evidence Report/Technology Assessment No. 193. (Prepared by the Duke Evidence-based Practice Center under Contract No. HHSA 290-2007-10066-I.) AHRQ Publication No. 10-E005. Agency for Healthcare Research and Quality: Rockville, MD.
181. Wilson RS, Segawa E, Boyle PA, Bennett DA. 2012. Influence of late-life cognitive activity on cognitive health. Neurology 78: 1123-1129.
182. World Health Organization. 2012. Dementia: a public health priority. WHO Geneva.
183. Xu WL, Atti AR, Gatz M, et al. 2011. Midlife overweight and obesity increase late-life dementia risk: a population-based twin study. Neurology 76: 1568-1574.
184. Yaffe K, Kanaya A, Lindquist K, et al. 2004. The metabolic syndrome, inflammation, and risk of cognitive decline. JAMA 292 : 2237-2242.
185. Yang YH, Roe CM, Morris JC. 2011. Relationship between late-life hypertension, blood pressure, and Alzheimer's disease. Am J Alzheimers Dis Other Demen 26: 457-462.
186. Yen CH, Yeh CJ, Wang CC, et al. 2010. Determinants of cognitive impairment over time among the elderly in Taiwan: results of the national longitudinal study. Arch Gerontol Geriatr 50 (Suppl 1): S53-S57.
187. Zahr NM, Kaufman KL, Harper CG. 2011. Clinical and pathological features of alcohol-related brain damage. Nat Rev Neurol 7: 284-294.
188. Zhou R, Deng J, Zhang M, Zhou HD, Wang YJ. 2011. Association between bone mineral density and the risk of Alzheimer's disease. J Alzheimers Dis 24 : 101-108.
189. Zuliani G, Cavalieri M, Galvani M, et al. 2010. Relationship between low levels of high-density lipoprotein cholesterol and dementia in the elderly. The InChianti study. J Gerontol A Biol Sci Med Sci 65: 559-564.